Billy Joel Postpones Tour Due to Brain Condition, Undergoes Therapy

Music legend Billy Joel has been diagnosed with normal pressure hydrocephalus (NPH), a neurological condition caused by an abnormal buildup of fluid in or around the brain. This condition can interfere with essential brain functions, impacting memory, movement, concentration, and even balance, according to the Cleveland Clinic. While symptoms may mimic dementia, NPH can sometimes be treated and even reversed.

The 76-year-old singer's team shared that the condition has been worsened by the physical demands of recent performances, leading to complications with his hearing, vision, and balance. On his physician's advice, Joel is now undergoing specialized physical therapy and will be stepping away from the stage during his recovery.

"Billy is grateful for the exceptional care he's receiving and deeply appreciative of the continued support from his fans," the statement read. "He's looking forward to returning to live performances once his recovery allows."

Joel also offered a personal message: "I'm sincerely sorry to disappoint our audience, and thank you for understanding."

Fans who purchased tickets need not take any action-refunds will be automatically issued to the original payment method, the statement confirmed.

The tour's canceled and postponed shows span a wide range of cities, including:

• Charlotte, North Carolina
• Cincinnati
• Detroit
• Edinburgh, Scotland
• East Rutherford, New Jersey
• Hollywood, Florida
• Liverpool, England
• Milwaukee
• New Orleans
• New York City (Bronx and Queens)
• Pittsburgh
• Salt Lake City
• Santa Clara, California
• Syracuse, New York
• Toronto
• Washington, D.C.

Several high-profile artists, including Sting, Rod Stewart, and Stevie Nicks, had been scheduled to join Joel for select dates on this tour. Some of these performances had already been rescheduled earlier this year following Joel's announcement in March that he was recovering from surgery.

Normal pressure hydrocephalus is most commonly diagnosed in adults over 65 and affects an estimated 8.4 million people over the age of 80 globally, per the Cleveland Clinic.